AEMD: Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial

Smartkarma
05-22

⬆ $Aethlon Medical (AEMD)$ - The in vitro testing examined the removal of EVs directly from plasma & was reviewed and examined by an independent 3rd party commercial lab...


Continue reading on Smartkarma:- https://www.smartkarma.com/insights/aemd-data-from-in-vitro-study-supports-advancing-planned-oncology-clinical-trial?utm_source=tiger_community

By Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community

On Aethlon Medical (AEMD):- https://www.smartkarma.com/entities/aethlon-medical-inc?utm_source=tiger_community

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment